Cargando…
Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations
The success of protein, peptide and antibody based therapies is evident - the biopharmaceuticals market is predicted to reach $388 billion by 2024 [1], and more than half of the current top 20 blockbuster drugs are biopharmaceuticals. However, the intrinsic properties of biopharmaceuticals has restr...
Autores principales: | Kirkby, Melissa, Hutton, Aaron R.J., Donnelly, Ryan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266419/ https://www.ncbi.nlm.nih.gov/pubmed/32488611 http://dx.doi.org/10.1007/s11095-020-02844-6 |
Ejemplares similares
-
Microneedles: A New Frontier in Nanomedicine Delivery
por: Larrañeta, Eneko, et al.
Publicado: (2016) -
Microneedle-mediated transdermal bacteriophage delivery
por: Ryan, Elizabeth, et al.
Publicado: (2012) -
Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding
por: Hutton, Aaron R.J., et al.
Publicado: (2018) -
Microneedles in Action: Microneedling and Microneedles-Assisted Transdermal Delivery
por: Lim, Dong-Jin, et al.
Publicado: (2022) -
Microneedle/nanoencapsulation-mediated transdermal delivery: Mechanistic insights
por: Gomaa, Yasmine A., et al.
Publicado: (2014)